Table 2.
After completion of treatment.
 |
01 | 06 | 07 | 08 | 010 | 015 | 032 | 037 | 041 | 044 |
|---|---|---|---|---|---|---|---|---|---|---|
| Age & Gender |
52, Male |
53, Female |
49, Male |
46, Male |
54, Male |
57, Male |
47, Male |
48, Male |
62, Male |
69, Male |
| Morbidity Present |
DM, Bp | DM | DM | – | DM | DM | – | – | – | DM, BP |
| CRP Value mg/Lit | 5 | 2.7 | 2.9 | 1.86 | 3.96 | 3.02 | 0.62 | 4.4 | 2.16 | 3.43 |
| Spo 2 |
96% |
97% |
97% |
96% |
98% |
94% |
97% |
96% |
96% |
94% |
 |
Normal |
Normal |
Normal |
Normal |
Normal |
Normal |
Normal |
Normal |
Normal |
Normal |
| Fever | N | N | N | N | N | N | N | N | N | N |
| Head ache | N | N | N | N | N | N | N | N | N | N |
| Cough | Y+ | N | Y+ | N | Y+ | N | N | N | N | N |
| Body ache | N | N | N | N | N | N | N | N | N | Y+ |
| Fatigue | N | N | N | N | N | N | N | N | Y+ | Y+ |
| Taste loss | N | N | N | N | N | N | N | N | N | N |
| Smell loss | N | N | N | N | N | N | N | N | N | N |
| Breathlessness | N | N | N | N | N | N | N | N | N | N |
| Dyspepsia | N | N | N | N | N | Y+ | N | Y+ | N | Y+ |
| Sr. Creatinine | – | 0.7 | 0.9 | – | 0.6 | 1.28 | 1.1 | 1.17 | 0.9 | 1.0 |
| SGPT | – | 16 | – | – | – | 37.5 | 34.0 | 68.9 | 26.5 | 24.7 |
| SGOT | – | 14 | – | – | – | 39.2 | 37.5 | 33.5 | 24.9 | 37.1 |
| COVID-19 antiB. | -- | -- | Present | 94.32 | present | 54.28 | 28.09 | -- | 32.09 | 42.98 |
Y- Yes, N- No, + mild, ++ moderate, +++ High/DM – Diabetes, Bp- Hypertensive/CRP- Critical reactive protein, Spo 2 is blood oxygen saturation, AntiB- Antibodies.